Skip to main contentSkip to navigation
Sirius Investors

PAHC Stock: Phibro Animal Health Corporation Stock Price, Analysis & Insights

Get live PAHC stock price $31.54, comprehensive Phibro Animal Health Corporation stock analysis, charts, news, and expert forecast. Real-time PAHC stock data and investment insights.

31.54
3.39%Today
PAHCPhibro Animal Health Corporation • NASDAQ Global Market • Healthcare
Market Cap
1.28B
Volume
136.53K
52W High
60.08
52W Low
23.57

Loading chart data...

Phibro Animal Health Corporation (PAHC) Overview

Phibro Animal Health Corporation (PAHC) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - Specialty & Generic industry . As of the latest trading session, PAHC trades at $31.54 with a market capitalization of 1.28B . Over the past 52 weeks, PAHC has traded between $23.57 and $60.08 , with the current price positioned at approximately 22% of thi...

Key Takeaways

  • Operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic)
  • Market cap: 1.28B
  • Current price: $31.54
  • 52-week range: $23.57 - $60.08
  • P/E ratio: 13.54

Investment Score

Annual (latest period)
Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Phibro Animal Health Corporation operates as a global entity focused on the research, production, and supply of a wide array of animal health and mineral nutrition solutions. While serving a global clientele, its primary market for livestock products...

Company Information

CEO
Jack Clifford Bendheim
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1940

Contact Information

Address
Glenpointe Centre East
Country
US

Investment Analysis & Business Insights

Healthcare
Drug Manufacturers - Specialty & Generic

Investment Highlights

Strong presence in the Healthcare sector with established market position

Valuation metrics suggest potential value opportunity (P/E: 13.5)

Lower volatility stock (Beta: 0.46) may provide portfolio stability

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for Phibro Animal Health Corporation shareholders
  • Market volatility can significantly impact stock price, especially for smaller companies
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for Phibro Animal Health Corporation
  • Investors should consider how Phibro Animal Health Corporation fits within their overall portfolio allocation
  • Valuation metrics suggest potential, but require fundamental analysis

Market Cap

1.28B

P/E Ratio (TTM)

13.54

Beta

0.46

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.